Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00904475 · ClinicalTrials.gov registry record · Phase 4
Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain
A Phase 4 study of Chronic Low Back Pain, sponsored by Endo Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
- 6
- Study locations
NCT00904475: Completed Phase 4 study of Chronic Low Back Pain, sponsored by Endo Pharmaceuticals.
NCT00904475 is a Phase 4 study of Chronic Low Back Pain that has completed, run by Endo Pharmaceuticals. The registered enrollment target is 102 participants, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (83% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00904475, a Phase 4 study of Chronic Low Back Pain, has completed, sponsored by Endo Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
- 6
- Study locations
Study Summary
Patients with moderate to severe chronic Low Back Pain (LBP) despite current analgesic treatment participated in a Phase IV clinical trial to evaluate the analgesic efficacy of the lidocaine patch 5% compared to placebo in treating moderate to severe chronic LBP.
Conditions Studied
Interventions
- DRUG Lidoderm®
Study Locations (6)
Alabama
- - Birmingham
- - Hueytown
Arizona
- - Phoenix
California
- - Mill Valley
Pennsylvania
- - Allentown
Utah
- - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2003-04 |
| Phase | Phase 4 |
What the finished NCT00904475 record still lists
NCT00904475 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Lidoderm® is the first listed.
NCT00904475 lists 6 locations in 5 states (Alabama, Arizona, California).
Frequently Asked Questions
What is clinical trial NCT00904475 about?
NCT00904475 is a clinical study titled "Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain". Patients with moderate to severe chronic Low Back Pain (LBP) despite current analgesic treatment participated in a Phase IV clinical trial to evaluate the analgesic efficacy of the lidocaine patch 5% compared to placebo in treating moderate to severe chronic LBP.
What is the current status of trial NCT00904475?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2003-04.
What conditions does trial NCT00904475 study?
This clinical trial studies the following conditions: Chronic Low Back Pain.
What interventions are being tested in trial NCT00904475?
The interventions under investigation include: Lidoderm® (DRUG).
Who is sponsoring clinical trial NCT00904475?
This trial is sponsored by Endo Pharmaceuticals, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00904475 being conducted?
This trial has 6 study locations across Alabama, Arizona, California, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00904475's enrollment target sits among peer trials
102 33rd of 71 higher than 39 of 71 other Chronic Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Biofreeze® vs. a Placebo on Chronic Low Back Pain Walking Gait Characteristics and Pain
ACTIVE NOT RECRUITING · Phase 4
-
Determining the Prognostic Value of Continuous Intrathecal Infusion
COMPLETED · Phase 4
-
The Back Pain Consortium Research Program Study
COMPLETED · Phase 4
-
Mobile Neurofeedback for Low Back Pain
RECRUITING · NA
-
Phenotyping Response to Spinal Cord Stimulation in Chronic Low Back Pain
RECRUITING · NA
-
Active Music-Based Intervention in Patients With Chronic Low Back Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia